Hey there! So, this article is talking about how some people who invest in cannabis (a plant that can be used as medicine) are also interested in psychedelics (like LSD or magic mushrooms). These psychedelic substances might help treat mental health problems like depression better than other medicines. Some companies are doing research and tests to show how safe and effective these psychedels are, but they're not allowed to sell them yet in the US. There are also special places in other countries where people can go for a vacation and use these substances legally to feel better. The article says that investing in psychedelics is different from investing in cannabis because it focuses more on medicine, not just fun or relaxation. Read from source...

1. The author uses vague terms such as "psychedelic" without defining them or explaining what they entail, making it difficult for readers to understand the subject matter and its implications. This creates confusion and misunderstanding among the audience, who may have different interpretations of what psychedelics are and how they affect people's health and well-being.
2. The author makes unsubstantiated claims about the therapeutic benefits of various psychedelics without providing any evidence or scientific research to back them up. This creates a sense of uncertainty and doubt among readers, who may question the credibility and validity of the author's arguments and opinions.
3. The author compares and contrasts cannabis investing with psychedels investing without acknowledging the differences in regulation, legality, and social acceptance between the two industries. This creates a false equivalence and oversimplification of the complex issues involved in both fields, which may mislead readers into making uninformed decisions or judgments about the potential opportunities and risks in each sector.
4. The author seems to have a biased perspective on psychedelics as a "therapeutic" solution for mental illnesses, without considering other possible applications or benefits of these substances. This creates an incomplete and narrow view of the psychedelics industry, which may limit readers' understanding of its full potential and scope.
5. The author ignores the historical and cultural context of psychedelic use and the impact it has had on society, art, music, spirituality, and social movements. This creates a lack of awareness and appreciation for the richness and diversity of human experience that is influenced by these substances, which may affect readers' perceptions and attitudes towards psychedelics and their users.

Positive

Key points:
- The article introduces opportunities in psychedelics investing for cannabis investors and executives who are curious about the emerging field.
- Psychedelics are mainly focused on therapeutic benefits, especially for treating mental illnesses, while recreational use is secondary or limited.
- The article mentions various developments in the psychedelics industry, such as clinical research, public listings, offshore retreats, and media coverage.
- The article compares and contrasts psychedelics with cannabis in terms of legalization, therapeutic potential, and market demand.